Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989778226> ?p ?o ?g. }
- W2989778226 abstract "Abstract Background Bladder cancer (BC) is the most common malignant disease of the urinary tract. Recurrent high grade non muscle invasive BC carries a serious risk for progression and subsequent metastases. The most common preclinical mouse model for bladder cancer relies on administration of N -butyl- N -(4-hydroxybutyl) nitrosamine (BBN) to mice. BBN-induced tumors in mice recapitulate the histology of human BC and were characterized with an overexpression of markers typical for basal-like cancer subtype in addition to a high mutational burden with frequent mutations in Trp53, similar to human muscle invasive BC. Methods Bladder cancer was induced in C57BL/6J male mice by administering the BBN in the drinking water. A thorough histopathological analysis of bladder specimen during and post BBN treatment was performed at 2, 4, 16, 20 and 25 weeks. RNA sequencing and qPCR was performed to assess the levels of expression of immunologically relevant genes at 2 weeks and 20 weeks during and post BBN treatment. Results We characterized the dynamics of the inflammatory response in the BBN-induced BC in mice. The treatment with BBN had gradually induced a robust inflammation in the first 2 weeks of administration, however, the inflammatory response was progressively silenced in the following weeks of the treatment, until the progression of the primary carcinoma. Tumors at 20 weeks were characterized with a marked upregulation of IL18 when compared to premalignant inflammatory response at 2 weeks. In accordance with this, we observed an increase in expression of IFNγ-responsive genes coupled to a pronounced lymphocytic infiltrate during the early stages of malignant transformation in bladder. Similar to human basal-like BC, BBN-induced murine tumors displayed an upregulated expression of immunoinhibitory molecules such as CTLA-4, PD-L1, and IDO1 which can lead to cytotoxic resistance and tumor escape. Conclusions Despite the recent advances in bladder cancer therapy which include the use of checkpoint inhibitors, the treatment options for patients with locally advanced and metastatic BC remain limited. BBN-induced BC in mice displays an immunological profile which shares similarities with human MIBC thus representing an optimal model for preclinical studies on immunomodulation in management of BC." @default.
- W2989778226 created "2019-12-05" @default.
- W2989778226 creator A5000827495 @default.
- W2989778226 creator A5018453565 @default.
- W2989778226 creator A5050873549 @default.
- W2989778226 creator A5059860574 @default.
- W2989778226 creator A5068291244 @default.
- W2989778226 creator A5071264613 @default.
- W2989778226 creator A5074098219 @default.
- W2989778226 creator A5085627433 @default.
- W2989778226 creator A5089566397 @default.
- W2989778226 date "2019-11-28" @default.
- W2989778226 modified "2023-10-13" @default.
- W2989778226 title "The dynamics of the inflammatory response during BBN-induced bladder carcinogenesis in mice" @default.
- W2989778226 cites W1502075862 @default.
- W2989778226 cites W1510735640 @default.
- W2989778226 cites W1554348880 @default.
- W2989778226 cites W1939830496 @default.
- W2989778226 cites W1963629940 @default.
- W2989778226 cites W1976470802 @default.
- W2989778226 cites W1978065313 @default.
- W2989778226 cites W1989461518 @default.
- W2989778226 cites W2002757935 @default.
- W2989778226 cites W2013617327 @default.
- W2989778226 cites W2023254105 @default.
- W2989778226 cites W2025260202 @default.
- W2989778226 cites W2027854940 @default.
- W2989778226 cites W2045575773 @default.
- W2989778226 cites W2051593018 @default.
- W2989778226 cites W2067964015 @default.
- W2989778226 cites W2068108952 @default.
- W2989778226 cites W2068523052 @default.
- W2989778226 cites W2100305481 @default.
- W2989778226 cites W2107018762 @default.
- W2989778226 cites W2124191877 @default.
- W2989778226 cites W2130410032 @default.
- W2989778226 cites W2133603792 @default.
- W2989778226 cites W2136731993 @default.
- W2989778226 cites W2151534844 @default.
- W2989778226 cites W2160084664 @default.
- W2989778226 cites W2202349529 @default.
- W2989778226 cites W2282267907 @default.
- W2989778226 cites W2289712604 @default.
- W2989778226 cites W2347101381 @default.
- W2989778226 cites W2398131194 @default.
- W2989778226 cites W2472778407 @default.
- W2989778226 cites W2509266256 @default.
- W2989778226 cites W2604273531 @default.
- W2989778226 cites W2655262992 @default.
- W2989778226 cites W2744586223 @default.
- W2989778226 cites W2753423724 @default.
- W2989778226 cites W2770073832 @default.
- W2989778226 cites W2781447571 @default.
- W2989778226 cites W2792403564 @default.
- W2989778226 cites W2794045287 @default.
- W2989778226 cites W2803613017 @default.
- W2989778226 cites W2804923662 @default.
- W2989778226 cites W2807693780 @default.
- W2989778226 cites W2883464812 @default.
- W2989778226 cites W2889646458 @default.
- W2989778226 cites W2909566946 @default.
- W2989778226 cites W382455 @default.
- W2989778226 cites W4211115520 @default.
- W2989778226 doi "https://doi.org/10.1186/s12967-019-02146-5" @default.
- W2989778226 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6883615" @default.
- W2989778226 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31779626" @default.
- W2989778226 hasPublicationYear "2019" @default.
- W2989778226 type Work @default.
- W2989778226 sameAs 2989778226 @default.
- W2989778226 citedByCount "20" @default.
- W2989778226 countsByYear W29897782262020 @default.
- W2989778226 countsByYear W29897782262021 @default.
- W2989778226 countsByYear W29897782262022 @default.
- W2989778226 countsByYear W29897782262023 @default.
- W2989778226 crossrefType "journal-article" @default.
- W2989778226 hasAuthorship W2989778226A5000827495 @default.
- W2989778226 hasAuthorship W2989778226A5018453565 @default.
- W2989778226 hasAuthorship W2989778226A5050873549 @default.
- W2989778226 hasAuthorship W2989778226A5059860574 @default.
- W2989778226 hasAuthorship W2989778226A5068291244 @default.
- W2989778226 hasAuthorship W2989778226A5071264613 @default.
- W2989778226 hasAuthorship W2989778226A5074098219 @default.
- W2989778226 hasAuthorship W2989778226A5085627433 @default.
- W2989778226 hasAuthorship W2989778226A5089566397 @default.
- W2989778226 hasBestOaLocation W29897782261 @default.
- W2989778226 hasConcept C104317684 @default.
- W2989778226 hasConcept C121608353 @default.
- W2989778226 hasConcept C126322002 @default.
- W2989778226 hasConcept C127561419 @default.
- W2989778226 hasConcept C142724271 @default.
- W2989778226 hasConcept C2776914184 @default.
- W2989778226 hasConcept C2778024521 @default.
- W2989778226 hasConcept C2779306644 @default.
- W2989778226 hasConcept C2779762690 @default.
- W2989778226 hasConcept C2780352672 @default.
- W2989778226 hasConcept C502942594 @default.
- W2989778226 hasConcept C55493867 @default.
- W2989778226 hasConcept C555283112 @default.
- W2989778226 hasConcept C71924100 @default.
- W2989778226 hasConcept C77411442 @default.